Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2465

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1
Chunk 2465
---
 grant funding,
and are listed as inventors in more than 50 patents.

Submission
of Matters to a Vote of Securityholders

On
March 28, 2025, we held an annual meeting of stockholders (the “Meeting”). The Inspector of Elections determined that there
were 59,790,931 represented of the 140,584,743 common shares of the Company at the meeting amounting to 42.530 % of voting shares. At
the Meeting, the Company’s stockholders approved the following proposals (with percentages relating to the number of shares voted
on each matter):

1.
Election of Directors

For
Against Abstain Broker Non-Vote

(1)
Dr. Chirinjeev Kathuria, M.D.

28,473,831
4,276,790 281,736 26,758,574

(2)
Elizabeth Ng, M.D.

30,342,761
2,414,667 274,929 26,758,574

(3)
Jonathan Kurtis, M.D., Ph.D

30,625,072
2,125,038 282,247 26,758,574

(4)
Michael Peterson

30,520,515
2,210,232 301,610 26,758,574

2.
Approval of a. Reverse Split of issued and outstanding shares of common stock approval in a range of 1:2 to 1:250.

For
Against Abstain

43,708,050
15,757,223 325,658

3.
Approval of 2025 Equity Compensation Plan.

For
Against Abstain Broker Non-Vote

28,773,654
4,136,878 121,825 26,758,574

4.
Ratification of Auditors Berkowitz Pollack & Brandt as our independent registered public accounting firm for the year ending December
31, 2025.

For
Against Abstain

55,487,338
3,329,999 973,594

5.
Approve a non-binding advisory vote regarding the compensation paid to our Named Executive Officers
(“Say-On-Pay”)

For
Against Abstain Broker Non-Vote

29,233,497
3,583,347 215,513 26,758,574

6.
Approve a non-binding advisory vote regarding the frequency of holding our Say-On-Pay vote.

Three
Years